Quantum Biopharma (QNTM) Operating Leases (2019 - 2022)

Quantum Biopharma has disclosed Operating Leases across 4 years of filings, most recently posting $38004.0 for Q4 2022.

• Operating Leases for Q4 2022 came in at $38004.0, down 85.12% year-over-year; the trailing twelve-month figure through Dec 2022 was $38004.0 (down 85.12% YoY), and the FY2022 annual result was $38004.0, down 85.12% from the prior year.
• Operating Leases came in at $38004.0 for Q4 2022 at Quantum Biopharma, down from $255356.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $255356.0 in Q4 2021 to a low of $38004.0 in Q4 2022.
• The 4-year median for Operating Leases is $118529.1 (2019), against an average of $132604.6.
• Across the five-year window, Operating Leases surged 102.72% in 2021 and plunged 85.12% in 2022, its largest moves.
• Quantum Biopharma's Operating Leases stood at $111096.2 in 2019, then increased by 13.38% to $125962.0 in 2020, then soared by 102.72% to $255356.0 in 2021, then slumped by 85.12% to $38004.0 in 2022.
• The last three Operating Leases figures came in at $38004.0 (Q4 2022), $255356.0 (Q4 2021), and $125962.0 (Q4 2020), per Business Quant data.